Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Advances in Hematology|October 12, 2010
Hodgkin's Disease in Patients with HIV InfectionMichele Spina, Antonino Carbone, Annunziata Gloghini, et al.
Maedica|July 8, 2026
Immunological Considerations and Biological Consequences of Intradiscal Needle Procedures: Implications for Chemo-Nucleolysis and Oxygen-Ozone TherapyAniello Langella, Marianno Franzini, Luigi Valdenassi, et al.
Antioxidants (Basel, Switzerland)|November 25, 2023
The Role of Ozone as an Nrf2-Keap1-ARE Activator in the Anti-Microbial Activity and Immunity Modulation of Infected WoundsMarianno Franzini, Luigi Valdenassi, Sergio Pandolfi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2008
Can the caregiver replace his/her elderly cancer patient in the physician-patient line of communication?Annalisa Giacalone, Renato Talamini, Michele Spina, et al.
Journal of Medical Microbiology|June 27, 2025
The ability of ozone to counteract multidrug-resistant bacteria if used as an adjunct therapy: a bioinformatic modellingSalvatore Chirumbolo, Giuseppe Masiello, Marianno Franzini, et al.
Cancer Treatment Reviews|May 16, 2006
Insight into the treatment of cancer in older patients: developments in the last decadeDaniele Bernardi, Domenico Errante, Umberto Tirelli, et al.
Psycho-Oncology|August 22, 2006
What elderly cancer patients want to know? Differences among elderly and young patientsAnnalisa Giacalone, Michela Blandino, Renato Talamini, et al.
Frontiers in Bioscience (Elite Edition)|June 3, 2010
Biomarkers in lung cancerAlessandra Bearz, Massimiliano Berretta, Alessandro Cappellani, et al.
Journal of Clinical Medicine|January 11, 2022
Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone AutohemotherapyUmberto Tirelli, Marianno Franzini, Luigi Valdenassi, et al.
International Immunopharmacology|August 16, 2020
Oxygen-ozone (O<sub>2</sub>-O<sub>3</sub>) immunoceutical therapy for patients with COVID-19. Preliminary evidence reportedMarianno Franzini, Luigi Valdenassi, Giovanni Ricevuti, et al.
Pageof 15